Skip to main content
. Author manuscript; available in PMC: 2022 Jun 28.
Published in final edited form as: Aliment Pharmacol Ther. 2021 Oct 18;55(3):318–326. doi: 10.1111/apt.16647

Figure 2.

Figure 2

Adjusted odds ratios for Crohn's disease and ulcerative colitis exposed to COCPs compared to non-use. Average months per year of exposure to COCPs are stratified in 3-monthly quantiles. Odds ratios and 95% confidence intervals are adjusted for Townsend score, body mass index, smoking status and history of polycystic ovarian syndrome, endometriosis, acne and pregnancy